The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons

Brain Research

Volumn 783, Issue 1, 1998, Pages 77-84

  Shen, Maoxing ^a   Thayer, Stanley A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Calcium channel; Cannabinoid; Hippocampus; Patch clamp

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANALGESICS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CELLS, CULTURED; HIPPOCAMPUS; MORPHOLINES; NAPHTHALENES; NEURAL PATHWAYS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0031911402     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01195-5     Document Type: Article

References (53)

1. Abele A.E., Scholz K.P., Scholz W.K., Miller R.J. Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neuron. 4:1990;413-419.
2. Abood M.E., Ditto K.E., Noel M.A., Showalter V.M., Tao Q. Isolation and expression of a mouse CB1 cannabinoid receptor gene - comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells. Biochem. Pharmacol. 53:1997;207-214.
3. Alzheimer C., Sutor B., Tenbruggencate G. Disinhibition of hippocampal CA3 neurons induced by suppression of an adenosine-A(1) receptor-mediated inhibitory tonus - presynaptic and postsynaptic components. Neuroscience. 57:1993;565-575.
4. Bidaut-Russell M., Devane W.A., Howlett A.C. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 55:1990;21-26.
5. 2+ channels in hippocampal mossy fiber synaptic transmission and long-term potentiation. Neuron. 12:1994;261-269.
6. Caulfield M.P., Brown D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106:1992;231-232.
7. Childers S.R., Fleming L., Konkoy C., Marckel D., Pacheco M., Sexton T., Ward S. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Ann. NY Acad. Sci. 654:1992;33-51.
8. Collins D.R., Pertwee R.G., Davies S.N. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. 115:1995;869-870.
9. Compton D.R., Gold L., Ward S.J., Balster R., Martin B.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from (delta)9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263:1992;1118-1126.
10. Compton D.R., Rice K.C., de Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265:1993;218-226.
11. D'Ambra T.E., Estep K.G., Bell M.R., Eissenstat M.A., Josef K.A., Ward S.J., Haycock D.A., Baizman E.R., Casiano F.M., Beglin N.C., Chippari S.M., Grego J.D., Kullnig R.K., Daley G.T. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 35:1992;124-135.
12. De Lean A., Munson P.J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioasay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235(2):1978;E97-E102.
13. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., Childers S.R. Cannabinoids modulate potassium current in cultured hippocampal neurons. Recept. Channels. 1:1993;121-134.
14. Dodge F.A., Rahamimoff R. Co-operative action of calcium ions in transmitter release at the neuromuscular junction. J. Physiol. 193:1967;419-432.
15. Gerard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:1991;129-134.
16. Grynkiewicz G., Peonie M., Tsien R.Y. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
17. Henry D.J., Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186:1995;91-94.
18. Howlett A. Cannabinoid inhibition of adenylate cyclase. Mol. Pharmacol. 27:1985;429-436.
19. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29:1986;307-313.
20. Jansen E.M., Haycock D.A., Ward S.J., Seybold V.S. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res. 575:1992;93-102.
21. Jung M., Calassi R., Rinaldi-Carmona M., Chardenot P., Lefur G., Soubrie P., Ourydonat F. Characterization of CB1 receptors on rat neuronal cell cultures - binding and functional studies using the selective receptor antagonist SR 141716a. J. Neurochem. 68:1997;402-409.
22. Kasai H. Aosaki t. and Fukuda J., Presynaptic Ca-antagonist omega-conotoxin irreversibly blocks N-type Ca-channels in chick sensory neurons. Neurosci. Res. 4:1987;228-235.
23. Kuster J.E., Stevenson J.I., Ward S.J., D'Ambra T.E., Haycock D.A. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264:1993;1352-1363.
24. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastomaglioma cells. Proc. Natl. Acad. Sci. USA. 89:1992;3825-3829.
25. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15:1995;6552-6561.
26. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
27. McCleskey E.W., Fox A.P., Feldman D., Cruz L.J., Olivera B.M., Tsien R.W., Yoshikami D. Calcium channel blockade by a peptide from conus: specificity and mechanism. Proc. Natl. Acad. Sci. USA. 84:1987;4327-4331.
28. Mintz I.M., Sabatini B.L., Regehr W.G. Calcium control of transmitter release at a cerebellar synapse. Neuron. 15:1995;675-688.
29. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., Adams M.E. P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature. 355:1992;827-830.
30. Munro S., Thomas K., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
31. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49:1996;707-714.
32. Piser T.M., Lampe R.A., Keith R.A., Thayer S.A. Complete and reversible block by omega-grammotoxin sia of glutamatergic synaptic transmission between cultured rat hippocampal neurons. Neurosci. Lett. 201:1995;135-138.
33. 2+ channel subtypes in cultured rat hippocampal neurons. Mol. Pharmacol. 48:1995;131-139.
34. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 15:1995;2995-3012.
35. Regehr W., Kehoe J., Ascher P., Armstrong C. Synaptically triggered action potentials in dendrites. Neuron. 11:1993;145-151.
36. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Soubrie P., Breliere J.C., Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56:1994;1941-1947.
37. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D.et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
38. Robinson H.P.C., Kawahara M., Jimbo Y., Torimitsu K., Kuroda Y., Kawana A. Periodic synchronized bursting and intracellular calcium transients elicited by low magnesium in cultured cortical neurons. J. Neurophysiol. 70:1993;1606-1616.
39. Rose K., Christine C., Choi D. Magnesium removal induces paroxysmal neuronal firing and NMDA receptor-mediated neuronal degeneration in cortical cultures. Neurosci. Lett. 115:1990;313-317.
40. Scanziani M., Capogna M., Gahwiler B.H., Thompson S.M. Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus. Neuron. 9:1992;919-927.
41. Schatz A.R., Lee M., Condie R.B., Pulaski J.T., Kaminski N.E. Cannabinoid receptors CB1 and CB2 - a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142:1997;278-287.
42. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurons. J. Physiol. 435:1991;373-393.
43. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16:1996;4322-4334.
44. 2+ transients using simultaneous microfluorimetry and electrophysiology. Pflugers Arch. 412:1988;216-223.
45. Thompson S.M., Capogna M., Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci. 16:1993;222-227.
46. Turner T.J., Dunlap K., Adams M.E. Calcium channels coupled to glutamate release identified by ω-Aga-IVA. Science. 3:1992;1.
47. Turner T.J., Lampe R.A., Dunlap K. Characterization of presynaptic calcium channels with ω-contoxin MVIIC and ω-grammotoxin SIA: role for a resistant calcium channel type in neurosecretion. Mol. Pharmacol. 47:1995;348-353.
48. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium currents in cultured rat hippocampal neurons. J. Neurophysiol. 78:1996;43-50.
49. 2+ loads. J. Neurophysiol. 72:1994;2563-2569.
50. Werth J.L., Thayer S.A. Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J. Neurosci. 14:1994;348-356.
51. 2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
52. Wu L.G., Saggau P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron. 12:1994;1139-1148.
53. Wu L.G., Saggau P. Pharmacological identification of two types of presynaptic voltage-dependent calcium channels at CA3-CA1 synapses of the hippocampus. J. Neurosci. 14:1994;5613-5622.